The AP-1 factor JUNB correlates with poor survival of patients with esophageal adenocarcinoma.

Sci Rep · 2025 · PMC12287255 · PMID 40701988

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significancep = 0.078so close (0.05 < p ≤ 0.1)

showed a trendno p-value reported

Interestingly, among patients who received neoadjuvant treatment prior to surgery, high cJUN expression showed a trend toward poorer overall survival, although this did not reach statistical significance (p = 0.078) (Fig. 3 A).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.